The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review

Jean-Pierre Lebeau, Jean-Sébastien Cadwallader, Isabelle Aubin-Auger, Alain Mercier, Thomas Pasquet, Emmanuel Rusch, Kristin Hendrickx, Etienne Vermeire, Jean-Pierre Lebeau, Jean-Sébastien Cadwallader, Isabelle Aubin-Auger, Alain Mercier, Thomas Pasquet, Emmanuel Rusch, Kristin Hendrickx, Etienne Vermeire

Abstract

Background: Therapeutic inertia has been defined as the failure of health-care provider to initiate or intensify therapy when therapeutic goals are not reached. It is regarded as a major cause of uncontrolled hypertension. The exploration of its causes and the interventions to reduce it are plagued by unclear conceptualizations and hypothesized mechanisms. We therefore systematically searched the literature for definitions and discussions on the concept of therapeutic inertia in hypertension in primary care, to try and form an operational definition.

Methods: A systematic review of all types of publications related to clinical inertia in hypertension was performed. Medline, EMbase, PsycInfo, the Cochrane library and databases, BDSP, CRD and NGC were searched from the start of their databases to June 2013. Articles were selected independently by two authors on the basis of their conceptual content, without other eligibility criteria or formal quality appraisal. Qualitative data were extracted independently by two teams of authors. Data were analyzed using a constant comparative qualitative method.

Results: The final selection included 89 articles. 112 codes were grouped in 4 categories: terms and definitions (semantics), "who" (physician, patient or system), "how and why" (mechanisms and reasons), and "appropriateness". Regarding each of these categories, a number of contradictory assertions were found, most of them relying on little or no empirical data. Overall, the limits of what should be considered as inertia were not clear. A number of authors insisted that what was considered deleterious inertia might in fact be appropriate care, depending on the situation.

Conclusions: Our data analysis revealed a major lack of conceptualization of therapeutic inertia in hypertension and important discrepancies regarding its possible causes, mechanisms and outcomes. The concept should be split in two parts: appropriate inaction and inappropriate inertia. The development of consensual and operational definitions relying on empirical data and the exploration of the intimate mechanisms that underlie these behaviors are now needed.

Figures

Figure 1
Figure 1
Systematic research flow chart.
Figure 2
Figure 2
Model of shared decision-making leading to either appropriate inaction or inappropriate inertia.

References

    1. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398–404. doi: 10.1161/01.HYP.0000142248.54761.56.
    1. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:10–17. doi: 10.1161/01.HYP.0000103630.72812.10.
    1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality : a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.
    1. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305–1315. doi: 10.1016/S0140-6736(01)06411-X.
    1. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, Van Zwieten PA. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press. 2009;18:308–347. doi: 10.3109/08037050903450468.
    1. National Clinical Guideline Centre. Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London: Royal College of Physicians; 2011.
    1. National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda: National Heart, Lung, and Blood Institute; 2004.
    1. Scheltens T, Bots ML, Numans ME, Grobbee DE, Hoes AW. Awareness, treatment and control of hypertension: the ‘rule of halves’ in an era of risk-based treatment of hypertension. J Hum Hypertens. 2007;21:99–106. doi: 10.1038/sj.jhh.1002123.
    1. Wang YR, Alexander GC, Stafford RS. Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States. Arch Intern Med. 2007;167:141–147. doi: 10.1001/archinte.167.2.141.
    1. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Bames CS. Clinical inertia. Ann Intern Med. 2001;135:825–834. doi: 10.7326/0003-4819-135-9-200111060-00012.
    1. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, Subramanian U, Hogan MM, Hofer TP. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med. 2008;148:717–727. doi: 10.7326/0003-4819-148-10-200805200-00004.
    1. Turner BJ, Hollenbeak CS, Weiner M, Ten Have T, Tang SSK. Effect of unrelated comorbid conditions on hypertension management. Ann Intern Med. 2008;148:578–586. doi: 10.7326/0003-4819-148-8-200804150-00002.
    1. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47:345–351. doi: 10.1161/01.HYP.0000200702.76436.4b.
    1. PRISMA statement. Transparent reporting of systematic reviews and meta-analysis.
    1. Glaser B. The constant comparative method of qualitative analysis. Soc Probl. 1965;4:436–445.
    1. Corbin J, Strauss A. Basics of Qualitative Research. Techniques and Procedures for Developing Grounded Theory-3rd ed. Los Angeles: Sage publications; 2008.
    1. Faria C, Wenzel M, Lee KW, Coderre K, Nichols J, Belletti DA. A narrative review of clinical inertia: focus on hypertension. J Am Soc Hypertens. 2009;3:267–276. doi: 10.1016/j.jash.2009.03.001.
    1. Byrnes PD. Why haven’t I changed that? Therapeutic inertia in general practice. Aust Fam Physician. 2011;40:24–28.
    1. Krakoff LR, Kronish IM. Guidelines, inertia, and judgment. Hypertension. 2011;58:544–545. doi: 10.1161/HYPERTENSIONAHA.111.178913.
    1. Allen JD, Curtiss FR, Fairman KA. Nonadherence, clinical inertia, or therapeutic inertia? J Manage Care Pharm. 2009;15:690–695.
    1. Scheen AJ. Inertia in clinical practice: causes, consequences, solutions. Rev Med Liege. 2010;65:232–238.
    1. Giugliano D, Esposito K. Clinical inertia as a clinical safeguard. JAMA. 2011;305:1591–1592. doi: 10.1001/jama.2011.490.
    1. Gil-Guillén V, Orozco-Beltrán D, Márquez-Contreras E, Durazo-Arvizu R, Cooper R, Pita-Fernández S, González-Segura D, Carratalá-Munuera C, Martín de Pablo JL, Pallarés V, Pertusa-Martínez S, Fernández A, Redón J. Is there a predictive profile for clinical inertia in hypertensive patients? Drugs Aging. 2011;28:981–992. doi: 10.2165/11596640-000000000-00000.
    1. Vinyoles E. Not only clinical inertia…. Hipertension. 2007;24:91–92.
    1. Reach G. Patient non-adherence and healthcare-provider inertia are clinical myopia. Diabetes Metab. 2008;34:382–385. doi: 10.1016/j.diabet.2008.02.008.
    1. Ardery G, Carter BL, Milchak JL, Bergus GR, Dawson JD, James PA, Franciscus C, Kim Y. Explicit and implicit evaluation of physician adherence to hypertension guidelines. J Clin Hypertens. 2007;9:113–119. doi: 10.1111/j.1524-6175.2007.06112.x.
    1. Rodrigo C, Amarasuriya M, Wickramasinghe S, Constantine GR. Therapeutic momentum: a concept opposite to therapeutic inertia. Int J Clin Pract. 2013;67:97–98.
    1. O’Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Biltz G. In: Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology) Henriksen K, Battles JB, Marks ES, Lewin DI, editor. Rockville: Agency for Healthcare Research and Quality; 2005. Clinical Inertia and Outpatient Medical Errors; pp. 293–308.
    1. Howes F, Hansen E, Williams D, Nelson M. Barriers to diagnosing and managing hypertension - a qualitative study in Australian general practice. Aust Fam Physician. 2010;39:511–516.
    1. Bosworth HB, Olsen MK, Dudley T, Orr M, Goldstein MK, Datta SK, McCant F, Gentry P, Simel DL, Oddone EZ. Patient education and provider decision support to control blood pressure in primary care: a cluster randomized trial. Am Heart J. 2009;157:450–456. doi: 10.1016/j.ahj.2008.11.003.
    1. Lin ND, Martins SB, Chan AS, Coleman RW, Bosworth HB, Oddone EZ, Shankar RD, Musen MA, Hoffman BB, Goldstein MK. AMIA Annual Symposium Proceedings Archives: 11–15 november 2006. Washington, DC: Edited by American Medical Informatics Association; 2006. Identifying barriers to hypertension guideline adherence using clinician feedback at the point of care; pp. 494–498.
    1. Heisler M, Hogan MM, Hofer TP, Schmittdiel JA, Pladevall M, Kerr EA. When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation. 2008;117:2884–2892. doi: 10.1161/CIRCULATIONAHA.107.724104.
    1. Cranney M, Warren E, Barton S, Gardner K, Walley T. Why do GPs not implement evidence-based guideline? A descriptive study. Fam Pract. 2001;18:359–363. doi: 10.1093/fampra/18.4.359.
    1. Roumie CL, Elasy TA, Wallston KA, Pratt S, Greevy RA, Liu X, Alvarez V, Dittus RS, Speroff T. Clinical inertia: a common barrier to changing provider prescribing behavior. Jt Comm J Qual Patient Saf. 2007;33:277–285.
    1. Nelson MR. From research and guidelines to the consultation: Five ways to improve blood pressure management in clinical practice. Med J Aust. 2009;191:111–112.
    1. Borzecki AM, Oliveria SA, Berlowitz DR. Barriers to hypertension control. Am Heart J. 2005;149:785–794. doi: 10.1016/j.ahj.2005.01.047.
    1. Phillips LS, Twombly JG. It’s time to overcome clinical inertia. Ann Intern Med. 2008;148:783–785. doi: 10.7326/0003-4819-148-10-200805200-00011.
    1. Letters, comments and responses. Will running the numbers first violate the principles of patient-centered care? Ann Intern Med. 2008;149:838–841. doi: 10.7326/0003-4819-149-11-200812020-00017.
    1. Viera AJ, Schmid D, Bostrom S, Yow A, Lawrence W, DuBard CA. Level of blood pressure above goal and clinical inertia in a Medicaid population. J Am Soc Hypertens. 2010;4:244–254. doi: 10.1016/j.jash.2010.07.003.
    1. Ferrari P. National Coordinators for the Reasons for not Intensifying Antihypertensive Treatment (RIAT) trial. Reasons for therapeutic inertia when managing hypertension in clinical practice in non-Western countries. J Hum Hypertens. 2009;23:151–159. doi: 10.1038/jhh.2008.117.
    1. Crowley MJ, Smith VA, Olsen MK, Danus S, Oddone EZ, Bosworth HB, Powers BJ. Treatment intensification in a hypertension telemanagement trial: clinical inertia or good clinical judgment? Hypertension. 2011;58:552–558. doi: 10.1161/HYPERTENSIONAHA.111.174367.
    1. Oliveria SA, Lapuerta P, McCarthy BD, L’Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413–420. doi: 10.1001/archinte.162.4.413.
    1. Banegas JR, Lundelin K, de la Figuera M, de la Cruz JJ, Graciani A, Rodríguez-Artalejo F, Puig JG. Physician perception of blood pressure control and treatment behavior in high-risk hypertensive patients: A cross-sectional study. PLoS One. 2011;6:e24569. doi: 10.1371/journal.pone.0024569.
    1. Safford MM, Shewchuk R, Qu H, Williams JH, Estrada CA, Ovalle F, Allison JJ. Reasons for not intensifying medications: differentiating ‘clinical inertia’ from appropriate care. J Gen Intern Med. 2007;22:1648–1655. doi: 10.1007/s11606-007-0433-8.
    1. Kennedy AG, MacLean CD. Clinical inertia: errors of omission in drug therapy. Am J Health Syst Pharm. 2004;61:401–404.
    1. Hicks PC, Westfall JM, Van Vorst RF, Bublitz Emsermann C, Dickinson LM, Pace W, Parnes B. Action or inaction? Decision making in patients with diabetes and elevated blood pressure in primary care. Diabetes Care. 2006;29:2580–2585. doi: 10.2337/dc06-1124.
    1. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–1465. doi: 10.1001/jama.282.15.1458.
    1. Campbell NC, Murchie P. Treating hypertension with guidelines in general practice. BMJ. 2004;329:523–524. doi: 10.1136/bmj.329.7465.523.
    1. Rose AJ, Shimada SL, Rothendler JA, Reisman JI, Glassman PA, Berlowitz DR, Kressin NR. The accuracy of clinician perceptions of ‘usual’ blood pressure control. J Gen Intern Med. 2008;23:180–183. doi: 10.1007/s11606-007-0464-1.
    1. Reach G. [Strict clinical inertia: always questionable] Médecine des Maladies Métaboliques. 2011;5(Suppl 2):57–61.
    1. Midlöv P, Ekesbo R, Johansson L, Gerward S, Persson K, Nerbrand C, Hedblad B. Barriers to adherence to hypertension guidelines among GPs in southern Sweden: a survey. Scand J Prim Health Care. 2008;26:154–159. doi: 10.1080/02813430802202111.
    1. Tinsel I, Buchholz A, Vach W, Siegel A, Dürk T, Buchholz A, Niebling W, Fischer KG. Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial. BMC Fam Pract. 2013;14:135. doi: 10.1186/1471-2296-14-135.
    1. Montgomery AA, Harding J, Fahey T. Shared decision making in hypertension: the impact of patient preferences on treatment choice. Fam Pract. 2001;18:309–313. doi: 10.1093/fampra/18.3.309.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit